Compare Cytokinetics Inc (CYTK) vs Oklo Inc (OKLO) Price & Performance

Cytokinetics IncTrade

Oklo IncTrade

Price performance (Past 24H)

Key statistics

Cytokinetics Inc vs Oklo Inc — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Oklo Inc trades at $47.77 (market cap $8.74B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Cytokinetics Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.

	CYTK	OKLO
Market Cap	$10.63B	$8.74B
Sector	Technology	Technology
52-Week High	$87.26	$174.14
52-Week Low	$34.31	$36.84
Enterprise Value	$10.74B	$6.28B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CYTK

View details →

OKLO

NuScale Power shares fall 32% YTD amid revenue drop and dilution, awaiting key contracts to rebound.24/7 Wall Street · 22 hours agoBearish Oklo posts first revenue with reactor milestone; AST SpaceMobile reports higher revenue but heavy launch loss.24/7 Wall Street · 1 day agoNeutral Oklo posts $1.2M Q2 revenue with 14% stock rise, but core tech validation and cost clarity remain uncertain.Seeking Alpha · 4 days agoNeutral View details →

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.